427 related articles for article (PubMed ID: 27070649)
1. Heart failure with preserved ejection fraction in hypertension.
Teo LY; Chan LL; Lam CS
Curr Opin Cardiol; 2016 Jul; 31(4):410-6. PubMed ID: 27070649
[TBL] [Abstract][Full Text] [Related]
2. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.
Paulus WJ; Tschöpe C
J Am Coll Cardiol; 2013 Jul; 62(4):263-71. PubMed ID: 23684677
[TBL] [Abstract][Full Text] [Related]
3. Left Atrial Remodeling and Atrioventricular Coupling in a Canine Model of Early Heart Failure With Preserved Ejection Fraction.
Zakeri R; Moulay G; Chai Q; Ogut O; Hussain S; Takahama H; Lu T; Wang XL; Linke WA; Lee HC; Redfield MM
Circ Heart Fail; 2016 Oct; 9(10):. PubMed ID: 27758811
[TBL] [Abstract][Full Text] [Related]
4. Myocardial Microvascular Inflammatory Endothelial Activation in Heart Failure With Preserved Ejection Fraction.
Franssen C; Chen S; Unger A; Korkmaz HI; De Keulenaer GW; Tschöpe C; Leite-Moreira AF; Musters R; Niessen HW; Linke WA; Paulus WJ; Hamdani N
JACC Heart Fail; 2016 Apr; 4(4):312-24. PubMed ID: 26682792
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular features of heart failure with preserved ejection fraction versus nonfailing hypertensive left ventricular hypertrophy in the urban Baltimore community: the role of atrial remodeling/dysfunction.
Melenovsky V; Borlaug BA; Rosen B; Hay I; Ferruci L; Morell CH; Lakatta EG; Najjar SS; Kass DA
J Am Coll Cardiol; 2007 Jan; 49(2):198-207. PubMed ID: 17222731
[TBL] [Abstract][Full Text] [Related]
6. Impaired myocardial oxygen availability contributes to abnormal exercise hemodynamics in heart failure with preserved ejection fraction.
van Empel VP; Mariani J; Borlaug BA; Kaye DM
J Am Heart Assoc; 2014 Dec; 3(6):e001293. PubMed ID: 25468660
[TBL] [Abstract][Full Text] [Related]
7. Hypertension as a Road to Treatment of Heart Failure with Preserved Ejection Fraction.
Hicklin HE; Gilbert ON; Ye F; Brooks JE; Upadhya B
Curr Hypertens Rep; 2020 Sep; 22(10):82. PubMed ID: 32880741
[TBL] [Abstract][Full Text] [Related]
8. Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fraction.
Mohammed SF; Hussain S; Mirzoyev SA; Edwards WD; Maleszewski JJ; Redfield MM
Circulation; 2015 Feb; 131(6):550-9. PubMed ID: 25552356
[TBL] [Abstract][Full Text] [Related]
9. Current Perspectives on Systemic Hypertension in Heart Failure with Preserved Ejection Fraction.
Tam MC; Lee R; Cascino TM; Konerman MC; Hummel SL
Curr Hypertens Rep; 2017 Feb; 19(2):12. PubMed ID: 28233237
[TBL] [Abstract][Full Text] [Related]
10. Prevention of heart failure with preserved ejection fraction (HFpEF): reexamining microRNA-21 inhibition in the era of oligonucleotide-based therapeutics.
Ben-Nun D; Buja LM; Fuentes F
Cardiovasc Pathol; 2020; 49():107243. PubMed ID: 32629211
[TBL] [Abstract][Full Text] [Related]
11. Myocardial stiffness in patients with heart failure and a preserved ejection fraction: contributions of collagen and titin.
Zile MR; Baicu CF; Ikonomidis JS; Stroud RE; Nietert PJ; Bradshaw AD; Slater R; Palmer BM; Van Buren P; Meyer M; Redfield MM; Bull DA; Granzier HL; LeWinter MM
Circulation; 2015 Apr; 131(14):1247-59. PubMed ID: 25637629
[TBL] [Abstract][Full Text] [Related]
12. Heart Failure With Preserved Ejection Fraction: Is Ischemia Due to Coronary Microvascular Dysfunction a Mechanistic Factor?
Elgendy IY; Pepine CJ
Am J Med; 2019 Jun; 132(6):692-697. PubMed ID: 30684452
[TBL] [Abstract][Full Text] [Related]
13. Cardiac diastolic and autonomic dysfunction are aggravated by central chemoreflex activation in heart failure with preserved ejection fraction rats.
Toledo C; Andrade DC; Lucero C; Arce-Alvarez A; Díaz HS; Aliaga V; Schultz HD; Marcus NJ; Manríquez M; Faúndez M; Del Rio R
J Physiol; 2017 Apr; 595(8):2479-2495. PubMed ID: 28181258
[TBL] [Abstract][Full Text] [Related]
14. Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction: A Multiorgan Roadmap.
Shah SJ; Kitzman DW; Borlaug BA; van Heerebeek L; Zile MR; Kass DA; Paulus WJ
Circulation; 2016 Jul; 134(1):73-90. PubMed ID: 27358439
[TBL] [Abstract][Full Text] [Related]
15. Dual Endothelin-A/Endothelin-B Receptor Blockade and Cardiac Remodeling in Heart Failure With Preserved Ejection Fraction.
Valero-Munoz M; Li S; Wilson RM; Boldbaatar B; Iglarz M; Sam F
Circ Heart Fail; 2016 Nov; 9(11):. PubMed ID: 27810862
[TBL] [Abstract][Full Text] [Related]
16. The role of arterial hypertension in development heart failure with preserved ejection fraction: just a risk factor or something more?
Tadic M; Cuspidi C; Frydas A; Grassi G
Heart Fail Rev; 2018 Sep; 23(5):631-639. PubMed ID: 29619635
[TBL] [Abstract][Full Text] [Related]
17. Heart Failure with Preserved Ejection Fraction and Future Pharmacological Strategies: a Glance in the Crystal Ball.
Tschöpe C; Van Linthout S; Kherad B
Curr Cardiol Rep; 2017 Aug; 19(8):70. PubMed ID: 28656481
[TBL] [Abstract][Full Text] [Related]
18. Relaxation and the Role of Calcium in Isolated Contracting Myocardium From Patients With Hypertensive Heart Disease and Heart Failure With Preserved Ejection Fraction.
Runte KE; Bell SP; Selby DE; Häußler TN; Ashikaga T; LeWinter MM; Palmer BM; Meyer M
Circ Heart Fail; 2017 Aug; 10(8):. PubMed ID: 28784688
[TBL] [Abstract][Full Text] [Related]
19. [The role of inflammation in heart failure with preserved ejection fraction].
Zhang Q; Chen YE; Zhu XX; Wang X; Qu AJ
Sheng Li Xue Bao; 2023 Jun; 75(3):390-402. PubMed ID: 37340648
[TBL] [Abstract][Full Text] [Related]
20. Myocardial reverse remodeling: how far can we rewind?
Rodrigues PG; Leite-Moreira AF; Falcão-Pires I
Am J Physiol Heart Circ Physiol; 2016 Jun; 310(11):H1402-22. PubMed ID: 26993225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
